Delivery of re-irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients.
Eva BerlinRachel EisenbergChristine Hill-KayserRobert A LustigGoldie KurtzElizabeth CummingsMichael LaRivierePublished in: Pediatric blood & cancer (2023)
The most common indication for PIPRT was reRT to provide durable tumor control. PIPRT appears to be safe, with no cases of high-grade toxicity.